University of Pittsburgh logo

Arthur Kim Ritchey, MD

  • Senior Vice Chair, Emeritus
  • Professor of Pediatrics

A. Kim Ritchey, MD is professor of pediatrics at the University of Pittsburgh School of Medicine in the Division of Hematology-Oncology. He currently is Senior Vice Chair, Emeritus in the department of pediatrics. He was the Division Chief of Hematology-Oncology for 15 years. He also served as Vice Chair for Clinical Affairs and Vice Chair for International Affairs

Ritchey earned his Bachelor of Arts degree from Dartmouth College and completed medical school at the University of Cincinnati. He completed residency in pediatrics at Johns Hopkins Hospital and fellowship in hematology-oncology at Yale University. 

Ritchey’s primary clinical and research interests are in leukemia and coagulation disorders. He developed a Children’s Oncology Group protocol for the treatment of isolated CNS leukemia that can be considered standard of care today. He served as the Chair of the Children’s Oncology Group Data Safety Monitoring Committee for 10 years. He has been a regional leader in the hemophilia community and served on the Executive Committee of Region III Federally Funded Hemophilia Treatment Centers for 10 years. He served as the President of the American Society of Pediatric Hematology-Oncology. He has also been the Editor-in-Chief of the Pediatric Data Query (PDQ), an NCI sponsored information system for state-of-the-art cancer treatment, for 30 years. He continues to care for children with hematologic and oncologic disorders and serves as a mentor for trainees in the field. 

Professional and Scientific Society Memberships

  • American Society of Pediatric Hematology/Oncology, 1981-Present
    • Nominating Committee, 2020-Present
  • American Society of Hematology, 1983-Present
  • American Soceity of Clinical Oncology, 1986-Present
  • Children's Oncology Group (COG), 2000-Present
    • Chairman, Data Safety Monitoring Committee A, 2013-Present
  • National Cancer Institute, Phsician Data Query, Pediatric Board, 1994-Present
    • Editior-in-Chief, 1997-Present
  • American Board of Pediatrics Medical Editor, 2023-Present

 

Education & Training

  • AB, Philosophy, Dartmouth College, 1968
  • MD, University of Cincinnati Medical College, 1972
  • Internship in Pediatrics, Johns Hopkins Hospital, 1972-1973
  • Residency in Pediatrics, Johns Hopkins Hospital, 1973-1975
  • Fellowship in Pediatric Hematology/Oncology, Yale University School of Medicine, 1977-1980

Selected Publications

Barredo JC, Hastings C, Lu XF, Devidas M, Chen Y, Armstrong D, Winick N, Wood BL, Yanofsky R, Loh M, Gastier-Foster JM, Jorstad DT, Marcus R, Ritchey K, Carroll WL, Hunger SP. Isolated late Testicular Relapse of B-cell Acute Lymphoblastic Leukemia Treated with Intensive Systemic Chemotherapy and Response-based Testicular Radiation: A Children’s Oncology Group Study. Pediatr Blood Cancer. 2018 May;65(5):e26928. doi: 10.1002/pbc.26928. Epub 2017 Dec 29 PMID:29286562

Meenan CK, Kelly JA, Ritchey AK, Maurer SH: Obesity in Pediatric Patients with Acute Lymphoblastic Leukemia increases the Risk of Adverse Events during Pre-maintenance chemotherapy. Pediatr Blood Cancer. 2019 Feb;66(2):e27515. doi: 10.1002/pbc.27515. Epub 2018 Oct 26. PMID:30362242

Hastings C, Chen Y, Devidas M, Ritchey AK, Winick NJ, Carroll WL, Hunger SP, Wood BL, Marcus RB, Barredo JC: Late isolated central nervous system relapse in childhood B-cell acute lymphoblastic leukemia treated with intensified systemic therapy and delayed reduced dose cranial radiation: A report from the Children's Oncology Group study AALL02P2. Pediatr Blood Cancer. 2021 Dec;68(12):. PMID: 34302704

Segal JE, Ritchey AK, Tersak J, Thakkar K, Lambore S: Pediatrician's Approach to Recognizing Neuroblastoma With Opsoclonus-Myoclonus-Ataxia Syndrome..Clin Pediatr (Phila). 2022 Dec 29:99228221147407. PMID: 36579856

Wang X, Singh P, Zhou L, Sharafeldin N, Landier W, Hageman L, Burridge P, Yasui Y, Sapkota Y, Blanco JG, Oeffinger KC, Hudson MM, Chow EJ, Armenian SH, Neglia JP, Ritchey AK, Hawkins DS, Ginsberg JP, Robison LL, Armstrong GT, Bhatia S:  Genome-Wide Association Study Identifies ROBO2 as a Novel Susceptibility Gene for Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors.  J Clin Oncol. 2023 Mar 20;41(9):1758-1769. PMID: 36508697

Wadhwa A, Chen Y, Hageman L, Hoppmann AL, Angiolillo A, Dickens DS, Lew G, Neglia JP, Ravindranath Y, Ritchey AK, Termuhlen A, Wong FL, Landier W, Bhatia S: Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report. Cancer. 2023 Jan 1;129(1):151-160. PMID: 36369905

Singh P, Crossman DK, Zhou L, Wang X, Sharafeldin N, Hageman L, Blanco JG, Burridge PW, Armenian SH, Balis FM, Hawkins DS, Keller FG, Hudson MM, Neglia JP, Ritchey AK, Ginsberg JP, Landier W, Bhatia S: Haptoglobin Gene Expression and Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors: A COG-ALTE03N1 Report.JACC CardioOncol. 2023 Feb 7;5(3):392-401. doi: 10.1016/j.jaccao.2022.09.009. eCollection 2023 Jun.PMID: 37397079

Wadhwa A, Chen Y, Hageman L, Hoppmann A, Angiolillo A, Dickens DS, Neglia JP, Ravindranath Y, Ritchey AK, Termuhlen A, Wong FL, Landier W, Bhatia S: Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children's Oncology Group study AALL03N1 report.  .Blood. 2023 Jul 20;142(3):221-229. doi: 10.1182/blood.2023019631.PMID: 37070673

Singh P, Zhou L, Shah DA, Cejas RB, Crossman DK, Jouni M, Magdy T, Wang X, Sharafeldin N, Hageman L, McKenna DE, Horvath S, Armenian SH, Balis FM, Hawkins DS, Keller FG, Hudson MM, Neglia JP, Ritchey AK, Ginsberg JP, Landier W, Burridge PW, Bhatia S. Identification of novel hypermethylated or hypomethylated CpG sites and genes associated with anthracycline-induced cardiomyopathy. Sci Rep. 2023 Aug 4;13(1):12683. doi: 10.1038/s41598-023-39357-2.PMID: 37542143

Singh P, Shah DA, Jouni M, Cejas RB, Crossman DK, Magdy T, Qiu S, Wang X, Zhou L, Sharafeldin N, Hageman L, McKenna DE, Armenian SH, Balis FM, Hawkins DS, Keller FG, Hudson MM, Neglia JP, Ritchey AK, Ginsberg JP, Landier W, Bhatia R, Burridge PW, Bhatia S: Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report..J Am Heart Assoc. 2023 Oct 3;12(19):e029954. doi: 10.1161/JAHA.123.029954. Epub 2023 Sep 26. PMID: 37750583 

Full Publication List via NIH PubMed »

Academic and Research Interests

  • Lymphoblastic leukemia
  • Hemophilia

Research Grants

Children’s Oncology Group Protocol CA180-372 A Phase 2 Multi-Center Study of Dasatanib added to Standard Chemotherapy for Philadelphia positive ALL. CHP PI: A. Kim Ritchey, MD, 1% effort; 6/12-6/18 (Closed); Total payments: $52,300; Bristol-Myers-Squibb.

A Single Arm, Open-label, Long-term Efficacy and Safety Study of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune Thrombocytopenia (ITP). CHP PI: A. Kim Ritchey, MD, 1 % effort; 12/15 – Ongoing; Total payments: $53,913; Amgen